Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2004
09/10/2004WO2004029287A3 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
09/10/2004WO2004025253A3 Method of visualizing proteins bound to protein-binding membranes
09/10/2004WO2004023867A3 Transgenic cancer models in fish
09/10/2004WO2004015420A8 Method for diagnosing multiple sclerosis
09/10/2004WO2004013604A3 Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays
09/10/2004WO2004012847A3 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers
09/10/2004WO2004009835A3 Method for identifying cellular growth inhibitors
09/10/2004WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections
09/10/2004WO2003106970A3 P27 prevents cellular migration
09/10/2004WO2003095977A3 Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells
09/10/2004WO2003094844A3 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
09/10/2004WO2003088125A3 System and method for integrated computer-aided molecular discovery
09/10/2004WO2003087123A3 Methods and kits for testing mutagenicity
09/10/2004WO2003082079A3 Diagnostics for the detection of acidovorax avenae subsp. citrulli, causal agent of bacterial fruit blotch in melons
09/10/2004WO2003078449A3 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins
09/10/2004WO2003076579A3 Cancer-linked gene as target for chemotherapy
09/10/2004WO2003069534A3 Analysis and management of molecular data and sequences
09/10/2004WO2003065146A3 Methods for placing, accepting, and filling orders for products and services
09/10/2004WO2003052074A3 Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides
09/10/2004WO2003045230A3 Novel compositions and methods for cancer
09/10/2004WO2003038129A3 Methods for assessing and treating leukemia
09/10/2004WO2003028539A3 Materials and methods for the diagnosis of pediatric tumors
09/10/2004WO2003016475A3 Nucleic acid and amino acid sequences involved in pain
09/10/2004WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
09/10/2004WO2002098890A3 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/10/2004WO2002097053A3 Small molecule antagonists of bcl2 family proteins
09/10/2004WO2002094780A3 Kinases and phosphatases
09/10/2004WO2002092840A3 Agents that regulate apoptosis
09/10/2004CA2555962A1 Random array dna analysis by hybridization
09/10/2004CA2519193A1 Methods for the early diagnosis of ovarian cancer
09/10/2004CA2517384A1 Methods of determining a chemotherapeutic regimen based on loss of heterozygosity at the thymidylate synthase locus
09/10/2004CA2517308A1 Tailored treatment suitable for different forms of mastocytosis
09/10/2004CA2517235A1 Methods and constructs for evaluation of rnai targets and effector molecules
09/10/2004CA2517076A1 Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer
09/10/2004CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
09/10/2004CA2516795A1 Circulating tumor cells (ctc's): early assessment of time to progression,_survival and response to therapy in metastatic cancer patients
09/10/2004CA2516794A1 Overexpression, purification and characterization of a thermolabile phosphatase
09/10/2004CA2516651A1 Methods of screening for trpm5 modulators
09/10/2004CA2516619A1 Glutamate transport modulatory compounds and methods
09/10/2004CA2516579A1 Method of detecting onset risk of encephalitis or encephalopathy
09/10/2004CA2516546A1 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays
09/10/2004CA2516463A1 Construction of a deafness gene chip
09/10/2004CA2515155A1 Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores
09/10/2004CA2515129A1 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
09/10/2004CA2514329A1 Methods for the treatment of renal cell carcinoma
09/09/2004US20040177397 Prenatal screening
09/09/2004US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders
09/09/2004US20040177387 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders
09/09/2004US20040176716 Electrode apparatus and method for the delivery of drugs and genes into tissue
09/09/2004US20040176625 Kinesin motor modulators derived from the marine sponge Adocia
09/09/2004US20040176599 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound
09/09/2004US20040176586 Process for detecting the presence or quantity of enzymatic activity in a sample
09/09/2004US20040176584 Methods for detecting, enumerating, quantifying, classifying and/or identifying total organismal DNA in a sample
09/09/2004US20040176583 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus
09/09/2004US20040176575 Compounds comprising modified secondary ligand binding site for treatment and prevention of infections, diabetes, emphysema, viral, endocrine and cell proliferative disorders
09/09/2004US20040176570 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
09/09/2004US20040176313 Inhibitors of Src kinase for use in alzheimer's disease
09/09/2004US20040176298 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
09/09/2004US20040175834 for monitoring efficacy and toxicity of cancer chemotherapy using mass spectrometry/spectrophotometry
09/09/2004US20040175811 Method for fixing biomolecules onto chemically inert surfaces
09/09/2004US20040175803 Interferon-alpha induced gene
09/09/2004US20040175791 DcR3 polypeptide, a TNFR homolog
09/09/2004US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering
09/09/2004US20040175785 by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids
09/09/2004US20040175781 Method of staining, detecting and counting bacteria, and a diluent for bacterial stain
09/09/2004US20040175780 Rapid and automated electrochemical method for detection of viable microbial pathogens
09/09/2004US20040175779 comprises the steps of creating a histogram with a high response side and a low response side of isolates and defining a limit for susceptibility interpretation and comparative analysis of antimicrobic resistance
09/09/2004US20040175777 Peptide substrate libraries comprising bifunctional fluorogenic-leaving group; specifically, 7-amino-4-carbamoylmethyl-coumarin (ACC) for profiling enzymatic activity; for drug screening enzyme inhibitors; solid phase synthesis
09/09/2004US20040175776 Assay method for platelet-activating factor
09/09/2004US20040175774 Method for predicting the sensitivity to chemotherapy
09/09/2004US20040175773 Screening method based on siah-numb interaction
09/09/2004US20040175770 by inducing or mimicking human gene activity causing the degradation of beta -catenin using genetically engineered cells/ animal models
09/09/2004US20040175768 Sensor for use in biological recognition; complexing biotinylated fluorescent polymer and a biotin-binding protein in aqueous solution
09/09/2004US20040175767 for lightening or darkening the pigmentation of cells and tissue (skin) in cells/cell-free systems; for drug screening
09/09/2004US20040175766 Human pyrimidine receptor
09/09/2004US20040175765 Cell-screening assay and composition
09/09/2004US20040175756 Methods for using combinatorial libraries of monomer domains
09/09/2004US20040175752 Real time quantitative PCR with intercalating dye for single and multiplex target DNA
09/09/2004US20040175750 without the use of radioactive agents by using apyrase, adenosine deaminase and alkaline phosphatase to remove non-cyclic adenine nucleotides; kits
09/09/2004US20040175748 Using alterations in cyclin dependent kinase activity to identify modulators which inhibit or potentiate cellular senescence; antiaging/anticancer agents; enzyme inhibitors
09/09/2004US20040175746 Method for HLA-typing
09/09/2004US20040175744 Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers
09/09/2004US20040175743 Using cancer marker gene expression profile in peripheral blood mononuclear cells to diagnose cell proliferative disorders and screen efficacy of antitumor agents
09/09/2004US20040175742 Biosensor and method for detecting macromolecular biopolymers using at least one unit for immobilizing macromolecular biopolymers
09/09/2004US20040175739 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/09/2004US20040175737 Detecting nuclease-mediated cleavage of target nucleic acids using dual labeled nucleotide sequences; hybridized sequences are associated with reduced fluorescent signal, cleaved sequences are associated increased fluorescence
09/09/2004US20040175736 Using nested oligonucleotide extension reaction to replicate preferential nucleotide sequences; gene expression analysis
09/09/2004US20040175734 Support for analyte determination methods and method for producing the support
09/09/2004US20040175733 Using reverse-transcription polymerase chain reaction to quantify expression of target gene sequences; gene expression analysis
09/09/2004US20040175732 in vivo and in vitro; for modulating the expression of a target gene in a cell by modulating the activity of an miRNA in the cell that targets the gene; genetic engineering
09/09/2004US20040175731 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides
09/09/2004US20040175729 Primer for nucleic acid amplification to detect carcinoembryonic antigen and test method using such primer
09/09/2004US20040175727 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
09/09/2004US20040175726 Compounds for protecting hydroxyls and methods for their use
09/09/2004US20040175724 for detection of mutations and single nucleotide polymorphisms, RNA molecules, pathogens, and of pre-cancerous or cancerous mutations and conditions
09/09/2004US20040175723 using oligonucleotide primers that hybridise to the genes encoding shiga-like toxin; for high throughput assays
09/09/2004US20040175719 Nucleotide sequences probes comprised of 20-60 bases for use as diagnostic tools and controls in genic analysis; bioassay
09/09/2004US20040175718 Computer-aided visualization and analysis system for sequence evaluation
09/09/2004US20040175717 Methods and kits for labeling and hybridizing cDNA for microarray analysis
09/09/2004US20040175716 Dna sequence analysis